Items where authors include "Abhishek, A."

Article

Abhishek, A. orcid.org/0000-0003-0121-4919, Grainge, M., Card, T. orcid.org/0000-0003-2555-2250 et al. (8 more authors) (2024) Risk-stratified monitoring for sulfasalazine toxicity: prognostic model development and validation. RMD Open, 10 (1). e003980. ISSN 2056-5933

Leaviss, J. orcid.org/0000-0002-5632-6021, Carroll, C. orcid.org/0000-0002-6361-6182, Essat, M. orcid.org/0000-0003-2397-402X et al. (5 more authors) (2024) Prognostic factors for liver, blood and kidney adverse events from glucocorticoid sparing immune-suppressing drugs in immune-mediated inflammatory diseases: a prognostic systematic review. RMD Open, 10 (1). e003588. ISSN 2056-5933

Abhishek, A., Peckham, N., Pade, C. et al. (65 more authors) (2023) Effect of a 2-week interruption in methotrexate treatment on COVID-19 vaccine response in people with immune-mediated inflammatory diseases (VROOM study): a randomised, open label, superiority trial. The Lancet Rheumatology. ISSN 2665-9913

Abhishek, A. orcid.org/0000-0003-0121-4919, Stevenson, M.D. orcid.org/0000-0002-3099-9877, Nakafero, G. orcid.org/0000-0002-3859-7354 et al. (12 more authors) (2023) Discontinuation of anti-TNF-alpha treatment due to blood test abnormalities and cost-effectiveness of alternate blood monitoring strategies. British Journal of Dermatology. ljad430. ISSN 0007-0963

Nakafero, G. orcid.org/0000-0002-3859-7354, Card, T., Grainge, M.J. et al. (9 more authors) (2023) Risk-stratified monitoring for thiopurine toxicity in immune-mediated inflammatory diseases: prognostic model development, validation, and, health economic evaluation. eClinicalMedicine, 64. 102213. ISSN 2589-5370

Nakafero, G. orcid.org/0000-0002-3859-7354, Grainge, M.J., Williams, H.C. et al. (9 more authors) (2023) Risk stratified monitoring for methotrexate toxicity in immune mediated inflammatory diseases: prognostic model development and validation using primary care data from the UK. BMJ, 381. e074678. ISSN 0959-8138

Abhishek, A., Boyton, R.J., McKnight, Á. et al. (15 more authors) (2022) Effects of temporarily suspending low-dose methotrexate treatment for 2 weeks after SARS-CoV-2 vaccine booster on vaccine response in immunosuppressed adults with inflammatory conditions: protocol for a multicentre randomised controlled trial and nested mechanistic substudy (Vaccine Response On/Off Methotrexate (VROOM) study). BMJ Open, 12 (5). e062599. ISSN 2044-6055

Doherty, M., Jenkins, W., Richardson, H. et al. (10 more authors) (2018) Efficacy and cost-effectiveness of nurse-led care involving education and engagement of patients and a treat-to-target urate-lowering strategy versus usual care for gout: a randomised controlled trial. Lancet, 392 (10156). pp. 1403-1412. ISSN 0140-6736

Proceedings Paper

Yaseen, K., Zhang, W., Doherty, M. et al. (16 more authors) (2023) What factors require consideration when individualising exercise interventions for people with osteoarthritis? Consensus of experts using a delphi methodology. In: Osteoarthritis and Cartilage. OARSI 2023, 17-20 Mar 2023, Denver. Elsevier .